Ytrium 90 as a radionuclide for therapy
Is a pure beta emitter with a half-life of 64.1h and 2.28 MeV of energy, suitable properties for its use as a therapeutic radionuclide. Radiopharmaceuticals based on have been effectively used in the treatment of different diseases such as chronic synovitis, liver cancer, pain caused by bone metast...
-д хадгалсан:
| Үндсэн зохиолч: | |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
Centro de Gestión de la Información y Desarrollo de la Energía (CUBAENERGIA)
2012-07-01
|
| Цуврал: | Nucleus |
| Нөхцлүүд: | |
| Онлайн хандалт: | http://nucleus.cubaenergia.cu/index.php/nucleus/article/view/574 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|